Beam Therapeutics Inc.
NASDAQ:BEAM · NASDAQ Global Select
+$0.48 today
Vol 2.74M · Avg 2.11M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+104.31%
Period High
$35.41
Period Low
$16.01
Latest
$34.14
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
ImmunityBio, Inc.
NASDAQ:IBRX
$7.40B
Cogent Biosciences, Inc.
NASDAQ:COGT
$5.90B
Denali Therapeutics Inc.
NASDAQ:DNLI
$3.73B
IDEAYA Biosciences, Inc.
NASDAQ:IDYA
$2.91B
Arcus Biosciences, Inc.
NYSE:RCUS
$2.44B
89bio, Inc.
ETNB
$2.20B
Agios Pharmaceuticals, Inc.
NASDAQ:AGIO
$2.00B
Galapagos N.V.
GLPG
$1.84B
Mineralys Therapeutics, Inc.
NASDAQ:MLYS
$1.69B
Recursion Pharmaceuticals, Inc.
NASDAQ:RXRX
$1.40B
What is the latest BEAM filing?
The latest filing shown is 8-K dated Jun 8, 2026.
How many recent filings does BEAM have?
Intrinsic Alpha currently shows 20 recent filings for BEAM.
Explore More
Continue the stock analysis
Jump to another research area for this company.